"Contracts awarded using the Special Reserve Fund are primarily of the fixed priced variety. BARDA has awarded 9 contracts for development and acquisition of CBRN medical countermeasures valued at over $2 billion, and has successfully stockpiled seventeen medical products against six CBRN threats.
The 2009 report details the status of several acquisition contracts, its recipients, total funding, and reasons specific authority use and terminated contracts."
